Evidence map›Paper›PMID 31094028›Full record

ArticleCell proliferation2019

Ginsenoside Rb3 provides protective effects against cisplatin-induced nephrotoxicity via regulation of AMPK-/mTOR-mediated autophagy and inhibition of apoptosis in vitro and in vivo.

Jing-Jing Xing, Jin-Gang Hou, Zhi-Na Ma, Zi Wang, Shen Ren, Ying-Ping Wang, Wen-Cong Liu, Chen Chen, Wei Li

Open access · goldAbstract read
In one paragraph

Article in Cell proliferation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Empagliflozin improves renal injury of diabetic nephropathy complicated with hyperuricemia through AMPK by promoting autophagy and inhibiting apoptosis.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Potential mechanism of ginseng in the treatment of periodontitis based on network pharmacology and molecular docking.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. A Hydrodistillate ofNutrients · 2022
    Article
  19. Article
  20. 1-ACS omega · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Jing-Jing XingCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
Jin-Gang HouCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
Zhi-Na MaCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
Zi WangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
Shen RenCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
Ying-Ping WangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
Wen-Cong LiuCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
Chen ChenSchool of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia.
Wei LiCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.ORCID https://orcid.org/0000-0002-2988-4298
Jilin Agricultural University · CNIntelligent Synthetic Biology Center · KRThe University of Queensland · AU

Funding

Jilin Science & Technology Development Plan 20160209008YYJilin Science & Technology Development Plan 20180201083YYJilin Science & Technology Development Plan 20190103092JHJilin Science & Technology Development Plan 20190304003YYJilin Science & Technology Development Plan 20191102051YYNational Natural Science Foundation of China 31770378Program for the Young Top-notch and Innovative Talents of Jilin Agricultural University 2016-2018Scientific Research Foundation for the Returned Overseas Chinese Scholars
6 · The paper itself

Abstract

objectivesBased on previous reports that ginsenosides have been shown to exert better preventive effects on cisplatin-induced kidney injury, the present work aims to evaluate the protective effects of ginsenoside Rb3 (G-Rb3) on cisplatin-induced renal damage and underlying mechanisms in vivo and in vitro. MATERIALS AND

methodsThe protective effect of G-Rb3 on cisplatin-induced acute renal failure in ICR mouse model and HEK293 cell model was investigated, and the underlying possible mechanisms were also explored. For animal experiment, renal function, kidney histology, inflammation, oxidative stress, relative protein molecules involved in apoptosis and autophagy signalling pathways were assessed. In addition, rapamycin (a specific inhibitor of mTOR), compound C (a specific inhibitor of AMPK) and acetylcysteine (NAC, a specific ROS scavenger) were employed to testify the effects of AMPK/mTOR signal pathway on the protective effects of G-Rb3 in HEK293 cells.

resultsPre-treatment with G-Rb3 at doses of 10 and 20 mg/kg for ten days significantly reversed the increases in serum creatinine (CRE), blood urea nitrogen (BUN) and malondialdehyde (MDA), and decrease in glutathione (GSH) content and superoxide dismutase (SOD) activity. Histopathological examination further revealed that G-Rb3 inhibited cisplatin-induced nephrotoxicity. G-Rb3 diminished cisplatin-induced increase in protein expression levels of p62, Atg3, Atg5 and Atg7, and decrease in protein expression level of p-mTOR and the ratio of LC3-I/LC3-II, indicating that G-Rb3 suppressed cisplatin-induced activation of autophagy. Inhibition of autophagy induced inactivation of apoptosis, which suggested that autophagy played an adverse effect on cisplatin-evoked renal damage. Further, we found that G-Rb3 might potentially modulate the expressions of AMPK-related signal pathways.

conclusionsThese findings clearly suggested that G-Rb3-mediated alleviation of cisplatin-induced nephrotoxicity was in part due to regulation of AMPK-/mTOR-mediated autophagy and inhibition of apoptosis in vitro and in vivo.

Indexed as

AMP-Activated Protein KinasesAnimalsApoptosisAutophagyBlood Urea NitrogenCell LineCisplatinCreatinineGinsenosidesGlutathioneHEK293 CellsHumansInflammationKidneyMaleMalondialdehydeAMP-Activated Protein KinasesCisplatinCreatinineginsenoside Rb3GinsenosidesGlutathioneMalondialdehydeMTOR protein, humanProtective AgentsSuperoxide DismutaseTOR Serine-Threonine KinasesAMPK/mTORautophagycisplatinGinsenoside Rb3HEK293 cellsnephrotoxicity

Identifiers

PMID31094028
PMCPMC6668974
OpenAlexW2945495921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.